CurrentCardio
Get Weekly

Cardiovascular journalCurrentCardio coverage

JAMA Cardiology

What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.

Recent
39 Briefs
past 90 days
Archive
358 Briefs
research published Apr 2023 – Dec 2026
Editorial
–
no Weekly issue published yet
Impact Factor
15.2
2025 · Journal Citation Reports

Topics

Evidence types

Shares are of the 358 Briefs CurrentCardio has covered from JAMA Cardiol, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from JAMA Cardiology

All coverage, newest first

  1. JAMA Cardiol

    Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease

    Meta-analysisHypertension

  2. JAMA Cardiol

    Global, Regional, and National Burden of Heart Failure, 1990-2023

    Cross-sectional studyHeart failure

  3. JAMA Cardiol

    Cardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart Failure

    Cohort studyHeart failure

  4. JAMA Cardiol

    No-Touch vs Conventional Vein Grafts in Coronary Surgery

    Secondary analysisCoronary & ACS

  5. JAMA Cardiol

    Loss of Chromosome Y and Risk of Abdominal Aortic Aneurysm

    Cohort studyAortic & peripheral

  6. JAMA Cardiol

    Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

    Research articleHeart failure

  7. JAMA Cardiol

    Lipoprotein(a) and Incident Venous Thromboembolism

    Cohort studyPulmonary vascular & VTE

  8. JAMA Cardiol

    Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure

    Secondary analysisHeart failure

  9. JAMA Cardiol

    Multidimensional Aging Trajectories Preceding Cardiovascular Events

    Case-control studyPrevention & lipids

  10. JAMA Cardiol

    Efficacy and Safety of Semaglutide According to Frailty Status

    Secondary analysisPrevention & lipids

  11. JAMA Cardiol

    Sex-Specific Outcomes After Catheter Ablation for AF in Left Ventricular Systolic Dysfunction

    Cross-sectional studyArrhythmias & EP

  12. JAMA Cardiol

    Long-Term Outcomes Following Bilateral vs Single Internal Thoracic Artery Grafts

    Secondary analysisCoronary & ACS

  13. JAMA Cardiol

    Atrial Dyssynchrony and Bachmann Bundle Pacing

    Research articleArrhythmias & EP

  14. JAMA Cardiol

    Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning

    Diagnostic or prognostic studyPrevention & lipids

  15. JAMA Cardiol

    Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease

    Randomised controlled trialPrevention & lipids

  16. JAMA Cardiol

    Effect of Acoramidis on Heart Failure–Related Health Status

    Secondary analysisHeart failure

  17. JAMA Cardiol

    Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023

    Research articleCoronary & ACS

  18. JAMA Cardiol

    Treadmill Stress Test in Patients With Asymptomatic Severe Aortic Stenosis

    Cohort studyValvular & structural

  19. JAMA Cardiol

    Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation

    Cohort studyValvular & structural

  20. JAMA Cardiol

    Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy

    Diagnostic or prognostic studyHeart failure

  21. JAMA Cardiol

    Causal Endotype–Based Classification of Myocardial Infarction

    Cohort studyCoronary & ACS

  22. JAMA Cardiol

    Machine Learning–Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy

    Cohort studyHeart failure

  23. JAMA Cardiol

    Artificial Intelligence–Enabled Acquisition and Interpretation for Screening Aortic Stenosis

    Diagnostic or prognostic studyValvular & structural

  24. JAMA Cardiol

    Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy

    Secondary analysisHeart failure

  25. JAMA Cardiol

    Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial Fibrillation

    Meta-analysisArrhythmias & EP

  26. JAMA Cardiol

    Intersectional Inequities in Age-Related Risk of Adverse Maternal Cardiometabolic Health

    Cross-sectional studyCardio-oncology & other

  27. JAMA Cardiol

    Myocardial Fibrosis and Reverse Remodeling After Valve Replacement in Chronic Aortic Regurgitation

    Cohort studyValvular & structural

  28. JAMA Cardiol

    Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy

    Secondary analysisHeart failure

  29. JAMA Cardiol

    Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI

    Secondary analysisHeart failure

  30. JAMA Cardiol

    U-Shaped Association Between Left Ventricular Dimension and Mortality in Patients With Heart Failure

    Cohort studyHeart failure

  31. JAMA Cardiol

    AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia

    Meta-analysisHeart failure

  32. JAMA Cardiol

    Cost Offset With Quadruple Therapy for Heart Failure

    Cohort studyHeart failure

  33. JAMA Cardiol

    Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk

    Meta-analysisCoronary & ACS

  34. JAMA Cardiol

    Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy

    Secondary analysisHeart failure

  35. JAMA Cardiol

    Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Secondary analysisHeart failure

  36. JAMA Cardiol

    Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis

    Cohort studyPrevention & lipids

  37. JAMA Cardiol

    Right Ventricular Metrics as End Points in Clinical Trials

    Research articleHeart failure

  38. JAMA Cardiol

    Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement

    Secondary analysisValvular & structural

  39. JAMA Cardiol

    Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification

    Randomised controlled trial

  40. JAMA Cardiol

    Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients

    Secondary analysisPulmonary vascular & VTE

All 358 Briefs in ExploreShowing the 40 most recently published